These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 71757)

  • 21. T cell lines with dual specificity for strong Mls and H-2 determinants.
    Molnar-Kimber KL; Webb SR; Sprent J; Wilson DB
    J Immunol; 1980 Dec; 125(6):2643-5. PubMed ID: 6159415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H-2 mutation affecting immune response to Thy-1.1 antigen.
    Zaleski M; Klein J
    J Exp Med; 1977 Jun; 145(6):1602-6. PubMed ID: 140918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gross reactivity between synthetic T,GA-L and transplantation antigens in CBA Mice.
    Ebringer A; Davies DA
    Nat New Biol; 1973 Jan; 241(109):144-7. PubMed ID: 4121713
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytostatic effector cells generated in vivo against M locus determinants.
    Matossian-Rogers A; Festenstein H
    Clin Exp Immunol; 1977 Feb; 27(2):335-9. PubMed ID: 66115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Mlsd-defined primary mixed lymphocyte reaction: a composite response to Mlsa and Mlsc determinants.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1987 Jun; 138(12):4085-92. PubMed ID: 2438333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces.
    Coutinho A; Augustin AA
    Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on non-H-2 linked lymphocyte activating determinants. I. Description of the cell type bearing the Mls product.
    Ahmed A; Scher I; Smith AH; Sell KW
    J Immunogenet; 1977 Jun; 4(3):201-13. PubMed ID: 70491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
    Lamon EW; Gatti RA; Kiessling R; Fenyö EM
    Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble suppressor of T cell proliferation in primary in vitro response to murine minor histocompatibility antigens.
    Solana R; Alonso MC; de la Fuente M; Alonso A; Peña J
    Rev Esp Fisiol; 1984 Sep; 40(3):341-52. PubMed ID: 6240742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants.
    Basten A; Miller JF; Abraham R
    J Exp Med; 1975 Mar; 141(3):547-60. PubMed ID: 46915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of tolerance against the MLs antigen in mice: no need for MLs-bearing cells.
    Lilliehöök B; Blomgren H; Jacobsson H; Andersson B
    Cell Immunol; 1977 Mar; 29(2):223-31. PubMed ID: 140765
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the cytotoxic T cell response to H-Y in CBA/H mice.
    Brenan M; Müllbacher A
    J Immunol; 1981 Aug; 127(2):681-5. PubMed ID: 6454725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of Mls-reactive T cells in H-2-compatible but Mls-incompatible bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsumoto K; Sakumoto M; Matsuzaki G; Nomoto K
    Eur J Immunol; 1989 Jun; 19(6):1009-13. PubMed ID: 2502418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of lymphocyte activating determinants from recognition sites in mouse MLR.
    Abbasi K; Festenstein H; Verbi W; Roitt IM
    Nature; 1974 Sep; 251(5472):227-9. PubMed ID: 4138667
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific neonatally induced tolerance to Mls locus determinants.
    Macphail S; Ishizaka ST; Bykowsky MJ; Lattime EC; Stutman O
    J Immunol; 1985 Nov; 135(5):2967-74. PubMed ID: 2413106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes.
    Scott JW; Ponzio NM; Orosz CG; Finke JH
    J Immunol; 1980 May; 124(5):2378-83. PubMed ID: 6444971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.